Testing the complete DNA of critically ill infants can lead to significant changes in treatment strategy, according to a newly published article by researchers at Children’s Mercy Hospital.
Genetic diseases are the leading cause of mortality in infants, according to Dr. Laurel K. Willig, a Children’s Mercy pediatric nephrologist and a lead author of the study.
She says many of these diseases may go undiagnosed, however, because of inadequate testing of critically ill newborns.
This story was republished with permission by KCUR
